CRSP

NASDAQStock

CRISPR Therapeutics AG

$48.67-1.19 (-2.38%)

52-Week Range

$31.27
$76.78

Key Stats

Market Cap

4.7B

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.74

Volume

2.5M

Avg Volume

2.6M

Performance

1M

+1.14%

3M

-13.12%

6M

-15.51%

YTD

-9.11%

1Y

+16.38%

3Y

+8.24%

5Y

-63.42%

Price Chart

ETF Exposure

CRSP is held by 91 ETFs

ETFFund NameWeight
GSSCGoldman Sachs ActiveBeta U.S. Small Cap Equity ETF0.04%
WSMLiShares MSCI World Small-Cap ETF0.04%
SMMDiShares Russell 2500 ETF0.04%
VFMOVanguard U.S. Momentum Factor ETF0.03%
OMFSInvesco Russell 2000 Dynamic Multifactor ETF0.03%
XTiShares Future Exponential Technologies ETF0.03%
HDGProShares - Hedge Replication ETF0.02%
STXVStrive 1000 Value ETF0.02%
MFDXPIMCO RAFI Dynamic Multi-Factor International Equity ETF0.02%
ONEQFIDELITY NASDAQ COMPOSITE INDEX ETF0.01%
TILTFlexShares Morningstar U.S. Market Factor Tilt Index Fund0.01%
ESGVVanguard ESG U.S. Stock ETF0.01%
ITOTiShares Core S&P Total U.S. Stock Market ETF0.01%
IWViShares Russell 3000 ETF0.01%
SCHBSchwab U.S. Broad Market ETF0.01%
AVUSAvantis U.S. Equity ETF0.01%
IYYiShares Dow Jones U.S. ETF0.01%
VTHRVanguard Russell 3000 ETF0.01%
V3AL.LVanguard ESG Global All Cap UCITS ETF (USD) Distributing0.01%
AVSUAvantis Responsible U.S. Equity ETF0.00%
STXGStrive 1000 Growth ETF0.00%
VTVanguard Total World Stock ETF0.00%
ITDFiShares LifePath Target Date 2050 ETF0.00%
ITDGiShares LifePath Target Date 2055 ETF0.00%
ITDHiShares LifePath Target Date 2060 ETF0.00%
ITDIiShares LifePath Target Date 2065 ETF0.00%
ITDJiShares LifePath Target Date 2070 ETF0.00%
EAOAiShares ESG Aware 80/20 Aggressive Allocation ETF0.00%
GTPEGoldman Sachs MSCI World Private Equity Return Tracker ETF0.00%
ITDEiShares LifePath Target Date 2045 ETF0.00%
EAOKiShares ESG Aware 30/70 Conservative Allocation ETF0.00%
EAOMiShares ESG Aware 40/60 Moderate Allocation ETF0.00%
EAORiShares ESG Aware 60/40 Balanced Allocation ETF0.00%
ITDCiShares LifePath Target Date 2035 ETF0.00%
ITDDiShares LifePath Target Date 2040 ETF0.00%
ITDBiShares LifePath Target Date 2030 ETF0.00%
LSLTPacer Salt Low truBeta US Market ETF0.00%
SLTPacer Salt High truBeta US Market ETF0.00%
TRPLPacer Metaurus US Large Cap Dividend Multiplier 300 ETF0.00%
VETSPacer Military Times Best Employers ETF0.00%
VIRSPacer BioThreat Strategy ETF0.00%
PreviousPage 2 of 2

About CRSP ETF Exposure

CRISPR Therapeutics AG (CRSP) is held by 91 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 4.7B, CRSP is a widely held institutional stock. The stock currently trades at $48.67. Investors can gain exposure to CRSP through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold CRSP, sorted by portfolio weight.